JNJ: anticipated imetelstat NME filing in 2017

Post by **Fishermangents** » Fri Dec 11, 2015 1:58 pm

This presentation is dated 20 May 2015. But I just found the presentation to be so comprehensive and important that I made it available through https://imetelstat.eu/commercial. It is a PDF (19 MB, 254 slides!) which downloads directly when you click on it. If it doesn't open you should get it from your Downloads folder.

slides 30 and 42: 10 $1B+ Next Wave of Billion Dollar Products (includes imetelstat)
slide 48: Innovation Across Therapeutic Areas (imetelstat listed under 'oncology')
slide 49: NME Filings Anticipated by 2019, each with $1B+ Potential (imetelstat listed for 2017)
slide 56: Confident decission making, based on deep expertise and early insughts (imetelstat listed under 'Heme Malignancies')
slide 64: Discovery Sciences, Powerful Support for Small Molecules (graph with imetelstat)
slide 80: Sustaining for Future Growth (imetestat listed under 'oncology asset')
slides 220-221: Myeloid Malignancies / Imetelstat: Disease Modifying Activity in Myeloid Malignancies
slide 239: Highlighted Next Generation Innovation / imetelstat listed

The presentation gives a good picture about the kind of partner JnJ is for Geron: I think the best we could wish for.